These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29374458)

  • 1. Unique depot formed by an oil based vaccine facilitates active antigen uptake and provides effective tumour control.
    Brewer KD; Weir GM; Dude I; Davis C; Parsons C; Penwell A; Rajagopalan R; Sammatur L; Bowen CV; Stanford MM
    J Biomed Sci; 2018 Jan; 25(1):7. PubMed ID: 29374458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using lymph node swelling as a potential biomarker for successful vaccination.
    Brewer KD; DeBay DR; Dude I; Davis C; Lake K; Parsons C; Rajagopalan R; Weir G; Stanford MM; Mansour M; Bowen CV
    Oncotarget; 2016 Jun; 7(24):35655-35669. PubMed ID: 27232944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clearance of depot vaccine SPIO-labeled antigen and substrate visualized using MRI.
    Brewer KD; Lake K; Pelot N; Stanford MM; DeBay DR; Penwell A; Weir GM; Karkada M; Mansour M; Bowen CV
    Vaccine; 2014 Dec; 32(51):6956-6962. PubMed ID: 25444822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel breast/ovarian cancer peptide vaccine platform that promotes specific type-1 but not Treg/Tr1-type responses.
    Karkada M; Weir GM; Quinton T; Sammatur L; MacDonald LD; Grant A; Liwski R; Juskevicius R; Sinnathamby G; Philip R; Mansour M
    J Immunother; 2010 Apr; 33(3):250-61. PubMed ID: 20445345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-compartmental vaccine delivery system for enhanced immune response to gp100 peptide antigen in melanoma immunotherapy.
    Kalariya M; Ganta S; Amiji M
    Pharm Res; 2012 Dec; 29(12):3393-403. PubMed ID: 22806408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemically administered gp100 encoding DNA vaccine for melanoma using water-in-oil-in-water multiple emulsion delivery systems.
    Kalariya M; Amiji MM
    Int J Pharm; 2013 Sep; 453(2):400-7. PubMed ID: 23702000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using MRI to evaluate and predict therapeutic success from depot-based cancer vaccines.
    DeBay DR; Brewer KD; LeBlanc SA; Weir GM; Stanford MM; Mansour M; Bowen CV
    Mol Ther Methods Clin Dev; 2015; 2():15048. PubMed ID: 26730395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using MRI cell tracking to monitor immune cell recruitment in response to a peptide-based cancer vaccine.
    Tremblay ML; Davis C; Bowen CV; Stanley O; Parsons C; Weir G; Karkada M; Stanford MM; Brewer KD
    Magn Reson Med; 2018 Jul; 80(1):304-316. PubMed ID: 29193231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradoxical decrease in the capture and lymph node delivery of cancer vaccine antigen induced by a TLR4 agonist as visualized by dual-mode imaging.
    Kadayakkara DK; Korrer MJ; Bulte JW; Levitsky HI
    Cancer Res; 2015 Jan; 75(1):51-61. PubMed ID: 25388285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CpG-mediated augmentation of CD8+ T-cell responses in mice is attenuated by a water-in-oil emulsion (Montanide ISA-51) but enhanced by an oil-in-water emulsion (IDRI SE).
    Makinen SR; Zhu Q; Davis HL; Weeratna RD
    Int Immunol; 2016 Sep; 28(9):453-61. PubMed ID: 27055469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose and timing requirements for immunogenicity of viral poultry vaccine antigen: investigations of emulsion-based depot function.
    Jansen T; Hofmans MP; Theelen MJ; Manders FG; Schijns VE
    Avian Pathol; 2007 Oct; 36(5):361-5. PubMed ID: 17899459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic vaccines and cancer: focus on DPX-0907.
    Karkada M; Berinstein NL; Mansour M
    Biologics; 2014; 8():27-38. PubMed ID: 24596453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microdosed Lipid-Coated (67)Ga-Magnetite Enhances Antigen-Specific Immunity by Image Tracked Delivery of Antigen and CpG to Lymph Nodes.
    Ruiz-de-Angulo A; Zabaleta A; Gómez-Vallejo V; Llop J; Mareque-Rivas JC
    ACS Nano; 2016 Jan; 10(1):1602-18. PubMed ID: 26678549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients.
    Berinstein NL; Karkada M; Morse MA; Nemunaitis JJ; Chatta G; Kaufman H; Odunsi K; Nigam R; Sammatur L; MacDonald LD; Weir GM; Stanford MM; Mansour M
    J Transl Med; 2012 Aug; 10():156. PubMed ID: 22862954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the adjuvant effect of water-in-oil-in-water (w/o/w) emulsion of sesame oil. 1. Enhanced and persistent antibody formation by antigen incorporated into the water-in-oil-in-water emulsion.
    Kimura J; Nariuchi H; Watanabe T; Matuhasi T; Okayasu I; Hatakeyama S
    Jpn J Exp Med; 1978 Apr; 48(2):149-54. PubMed ID: 713123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTL induction using synthetic peptides delivered in emulsions--critical role of the formulation procedure.
    Singh M; Hioe C; Qiu H; Li XM; Wang CY; Koff W; Zamb T; Nixon DF
    Vaccine; 1997 Nov; 15(16):1773-8. PubMed ID: 9364682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunogenicity-enhancing effect of emulsion vaccine adjuvants is independent of the dispersion type and antigen release rate--a revisit of the role of the hydrophile-lipophile balance (HLB) value.
    Yang YW; Wei AC; Shen SS
    Vaccine; 2005 Apr; 23(20):2665-75. PubMed ID: 15780450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Water-in-sorbitan monostearate organogels (water-in-oil gels).
    Murdan S; van den Bergh B; Gregoriadis G; Florence AT
    J Pharm Sci; 1999 Jun; 88(6):615-9. PubMed ID: 10350497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphatic-targeted cationic liposomes: a robust vaccine adjuvant for promoting long-term immunological memory.
    Wang C; Liu P; Zhuang Y; Li P; Jiang B; Pan H; Liu L; Cai L; Ma Y
    Vaccine; 2014 Sep; 32(42):5475-83. PubMed ID: 25110295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A non-ionic surfactant vesicle-in-water-in-oil (v/w/o) system: potential uses in drug and vaccine delivery.
    Yoshioka T; Skalko N; Gursel M; Gregoriadis G; Florence AT
    J Drug Target; 1995; 2(6):533-9. PubMed ID: 7773616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.